Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

Clinical and Translational Radiation Oncology - Tập 37 - Trang 145-152 - 2022
Anand Swaminath1, Marcin Wierzbicki2, Sameer Parpia3, Vijayananda Kundapur4, Sergio Faria5, Naseer Ahmed6, Alexis Bujold7, Khalid Hirmiz8, Timothy Owen9, Nelson Leong10, Kevin Ramchandar11, Edith Filion12, Harold Lau13, Robert Thompson14, Brian Yaremko15, Zsolt Gabos16, Selma Mehiri17, James R. Wright1, Theodoros K. Tsakiridis1, Kathryn Cline3
1Juravinski Cancer Centre, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada
2Juravinski Cancer Centre, McMaster University, Department of Medical Physics, 699 Concession Street, Hamilton, ON L8V 5C2, Canada
3Ontario Clinical Oncology Group, McMaster University, Department of Oncology, 699 Concession Street, Hamilton, ON L8V 5C2, Canada
4Saskatchewan Cancer Agency, University of Saskatchewan, Department of Radiation Oncology, 20 Campus Drive, Saskatoon, SK S7N 4H4, Canada
5Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
6Department of Radiology, Section of Radiation Oncology, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba Research Institute, Winnipeg, Manitoba, Canada
7Département de Radio-oncologie Clinique-Enseignement-Recherche, Centre intégré universitaire de soins et services sociaux de l’Est-de-l’Île-de-Montréal - Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada
8Department of Radiation Oncology, Windsor Regional Cancer Centre, Windsor, Ontario, Canada
9Department of Oncology, Queen's University, Cancer Centre of Southeast Ontario at Kingston Health Sciences Centre, Kingston, Ontario, Canada
10Allan Blair Cancer Centre, Department of Radiation Oncology, University of Saskatchewan, Regina, Saskatchewan, Canada
11Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada
12Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Notre Dame Hospital, Montréal, Quebec, Canada
13Department of Oncology, University of Calgary, Calgary, Alberta, Canada
14Department of Radiation Oncology, Dalhousie University, Saint John, New Brunswick, Canada
15Department of Radiation Oncology, Western University, London, Ontario, Canada
16Department of Oncology, University of Alberta, Edmonton, Alberta, Canada
17Département de Radio-oncologie, CISSS Montérégie, Hôpital Charles Lemoyne, Montréal, Quebec, Canada

Tài liệu tham khảo

Weber, 2011, Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting, Radiother Oncol J Eur Soc Ther Radiol Oncol, 100, 150, 10.1016/j.radonc.2011.05.073 Jaccard, 2020, Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial, Int J Radiat Oncol Biol Phys, 108, 1047, 10.1016/j.ijrobp.2020.06.002 Brade, 2018, Radiation Therapy Quality Assurance (RTQA) of concurrent chemoradiation therapy for locally advanced non-small cell lung cancer in the PROCLAIM phase 3 trial, Int J Radiat Oncol Biol Phys, 101, 927, 10.1016/j.ijrobp.2018.04.015 Fairchild, 2013, Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review, Int J Radiat Oncol Biol Phys, 87, 246, 10.1016/j.ijrobp.2013.03.036 Peters, 2010, Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02, J Clin Oncol Off J Am Soc Clin Oncol, 28, 2996, 10.1200/JCO.2009.27.4498 Corrigan, 2021, The radiotherapy quality assurance gap among phase III cancer clinical trials, Radiother Oncol J Eur Soc Ther Radiol Oncol, 166, 51, 10.1016/j.radonc.2021.11.018 Swaminath, 2017, Clin Lung Cancer, 18, 250, 10.1016/j.cllc.2016.08.002 Videtic, 2015, A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927), Int J Radiat Oncol Biol Phys, 93, 757, 10.1016/j.ijrobp.2015.07.2260 Kong, 2011, Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus, Int J Radiat Oncol Biol Phys, 81, 1442, 10.1016/j.ijrobp.2010.07.1977 Nagata, 2005, Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame, Int J Radiat Oncol Biol Phys, 63, 1427, 10.1016/j.ijrobp.2005.05.034 Hiraoka, 2007, A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 2, S115 Lambrecht, 2019, Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results, Radiother Oncol J Eur Soc Ther Radiol Oncol, 132, 63, 10.1016/j.radonc.2018.10.025 Kron, 2018, Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer, Br J Radiol, 91, 20170737, 10.1259/bjr.20170737 Matsuo, 2007, Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer, Int J Radiat Oncol Biol Phys, 68, 416, 10.1016/j.ijrobp.2006.12.012 Trada, 2015, Optimizing radiation therapy quality assurance in clinical trials: A TROG 08.03 RAVES substudy, Int J Radiat Oncol Biol Phys, 93, 1045, 10.1016/j.ijrobp.2015.08.029 Boustani, 2019, Quality assurance of dose-escalated radiation therapy in a randomized trial for locally advanced oesophageal cancer, Int J Radiat Oncol Biol Phys, 105, 329, 10.1016/j.ijrobp.2019.06.2542 Lo, 2014, The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 9, 527 Matuszak, 2016, Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy, Pract Radiat Oncol, 6, e39, 10.1016/j.prro.2015.09.009 Moghanaki, 2020, Assessing the variability and quality of lung stereotactic radiation therapy treatment plans using a web-based crowdsourcing platform, Pract Radiat Oncol, 10, e118, 10.1016/j.prro.2019.12.004 Rim, 2019, Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis, Int J Radiat Biol, 95, 329, 10.1080/09553002.2019.1552375 Tekatli, 2016, Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with “ultracentral” non-small cell lung cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 11, 1081 Chen, 2019, Safety and effectiveness of stereotactic ablative radiotherapy for ultra-central lung lesions: A systematic review, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 14, 1332 Lindberg, 2021, The HILUS-Trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 16, 1200 Lodeweges, 2021, Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy, Acta Oncol Stockh Swed, 60, 1061, 10.1080/0284186X.2021.1942545 Jasper, 2021, Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration, Adv Radiat Oncol, 6, 100750, 10.1016/j.adro.2021.100750 Clark, 2017, The role of dosimetry audit in lung SBRT multi-centre clinical trials, Phys Med, 44, 171, 10.1016/j.ejmp.2017.04.003
Thông tin
Thông tin xuất bản

Clinical and Translational Radiation Oncology

Tập 37

145-152

Thông tin tác giả